Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Adelson

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
JCO Oncology Practice|August 12, 2021
Impact of a Dedicated Cancer Urgent Care Center on Acute Care UtilizationBonnie E Gould Rothberg, Maureen E Canavan, Sophia Mun, et al.
JAMA Oncology|April 5, 2019
Treatment-Related Complications of Systemic Therapy and RadiotherapyVikram Jairam, Victor Lee, Henry S Park, et al.
Cancer|September 14, 2023
Oncology hospitalist impact on hospice utilizationElizabeth Prsic, Jensa C Morris, Kerin B Adelson, et al.
Journal of Palliative Medicine|July 11, 2024
Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple MyelomaSophia Shimer, Olivia S Allen, Chen Yang, et al.
Journal of Hospital Medicine|March 9, 2023
Outcomes on an inpatient oncology service after the introduction of hospitalist comanagementJensa C Morris, Bonnie E Gould Rothberg, Elizabeth Prsic, et al.
JCO Oncology Practice|July 18, 2020
Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of LifeFauzia Riaz, Geliang Gan, Fangyong Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2025
Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care QualityMaureen E Canavan, Lee Cheng, Jenny Jing Xiang, et al.
Clinical Breast Cancer|November 26, 2021
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)Denise A Yardley, Robyn R Young, Kerin B Adelson, et al.
Journal of Geriatric Oncology|February 6, 2019
Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancerFauzia Riaz, Carolyn J Presley, Anne C Chiang, et al.
JAMA Oncology|July 24, 2015
Chemotherapy Use, Performance Status, and Quality of Life at the End of LifeHolly G Prigerson, Yuhua Bao, Manish A Shah, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
JCO Oncology Practice|August 12, 2021
Impact of a Dedicated Cancer Urgent Care Center on Acute Care UtilizationBonnie E Gould Rothberg, Maureen E Canavan, Sophia Mun, et al.
JAMA Oncology|April 5, 2019
Treatment-Related Complications of Systemic Therapy and RadiotherapyVikram Jairam, Victor Lee, Henry S Park, et al.
Cancer|September 14, 2023
Oncology hospitalist impact on hospice utilizationElizabeth Prsic, Jensa C Morris, Kerin B Adelson, et al.
Journal of Palliative Medicine|July 11, 2024
Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple MyelomaSophia Shimer, Olivia S Allen, Chen Yang, et al.
Journal of Hospital Medicine|March 9, 2023
Outcomes on an inpatient oncology service after the introduction of hospitalist comanagementJensa C Morris, Bonnie E Gould Rothberg, Elizabeth Prsic, et al.
JCO Oncology Practice|July 18, 2020
Adoption of Immune Checkpoint Inhibitors and Patterns of Care at the End of LifeFauzia Riaz, Geliang Gan, Fangyong Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2025
Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care QualityMaureen E Canavan, Lee Cheng, Jenny Jing Xiang, et al.
Clinical Breast Cancer|November 26, 2021
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)Denise A Yardley, Robyn R Young, Kerin B Adelson, et al.
Journal of Geriatric Oncology|February 6, 2019
Disparities in broad-based genomic sequencing for patients with advanced non-small cell lung cancerFauzia Riaz, Carolyn J Presley, Anne C Chiang, et al.
JAMA Oncology|July 24, 2015
Chemotherapy Use, Performance Status, and Quality of Life at the End of LifeHolly G Prigerson, Yuhua Bao, Manish A Shah, et al.
Pageof 4